跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
邱 一航
成員
,
臺北神經醫學中心
https://orcid.org/0000-0002-3012-5643
h-index
263
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2024
每年研究成果
概覽
指紋
網路
研究成果
(26)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Hang Chiu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Neuroscience
Dementia Praecox
100%
Bipolar Disorder
62%
Major Depressive Disorder
62%
Placebo
50%
Sleep Quality
40%
Pediatric Trauma
40%
Oxytocin
40%
Antidepressant
27%
Mood Disorder
25%
Bipolar II Disorder
22%
Meta-Analysis
22%
Clozapine
21%
Adiponectin
20%
Glutamate Dehydrogenase
20%
MicroRNA
20%
Sleep Disorder
20%
Receptor Gene
20%
Oxytocin Receptor
20%
Leptin
20%
DNA Polymorphism
20%
Genome-Wide Association Study
20%
Topiramate
20%
Physical Dependence
20%
Cyanocobalamin
20%
Folic Acid
20%
Folate
20%
Negative Syndrome
12%
Fatty Acid Binding Protein 2
10%
Somatics
10%
C-Reactive Protein
10%
Necrosis
10%
Hamilton Rating Scale for Depression
10%
Depression
10%
Positive Syndrome
9%
Cognitive Function
9%
Selective Serotonin Reuptake Inhibitor
8%
Serotonin-Norepinephrine Reuptake Inhibitor
8%
Typical Antipsychotic
7%
Electroconvulsive Therapy
5%
Interleukin 6
5%
Mental Disorder
5%
Probiotic Agent
5%
Medicine and Dentistry
Gut Microbiota
55%
Major Depressive Episode
40%
Lactobacillus plantarum
40%
Symptom
26%
Antidepressant
22%
Placebo
22%
Delayed Hypersensitivity
20%
Meta-Analysis
20%
Hashimoto Encephalopathy
20%
Presenile Dementia
20%
Carbamazepine
20%
DRESS Syndrome
20%
Negative Syndrome
20%
Anhedonia
20%
Clozapine
20%
Placebo-Controlled Study
20%
Systematic Review
20%
Mental Health
20%
Typical Antipsychotic
16%
Disease
15%
Biological Marker
13%
Cognition
13%
Gut
13%
Cognitive Behavioral Therapy
12%
Pulse Rate
11%
Combination Therapy
11%
Early Diagnosis
10%
Thyroid Antibody
10%
Counseling
10%
Electrical Brain Stimulation
9%
Somatics
9%
Fatty Acid Binding Protein 2
9%
Tumor Necrosis Factor
9%
Hamilton Rating Scale for Depression
9%
C Reactive Protein
9%
Randomized Controlled Trial
8%
Selective Serotonin Reuptake Inhibitor
8%
Serotonin-Norepinephrine Reuptake Inhibitor
8%
Depression
8%
Psychoactive Drug
7%
Drug Therapy
7%
Adverse Event
6%
Dorsolateral Prefrontal Cortex
6%
Positive Syndrome
6%
Univariate Analysis
6%
Multivariate Analysis
6%
Electroconvulsive Therapy
5%
Subclinical Hypothyroidism
5%
Lactobacillus
5%
Cognitive Defect
5%
Nursing and Health Professions
Social Distance
35%
Disease
26%
Biological Marker
20%
Cross-Sectional Study
20%
Metabolic Syndrome X
20%
Nursing Student
20%
Medical Student
20%
Meta Analysis
20%
Negative Syndrome
20%
Adiponectin
20%
Leptin
20%
Typical Antipsychotic
13%
Sample Size
8%
Practice Guideline
6%
Symptom
6%
Combination Therapy
6%
Embase
6%
Placebo
6%
Adverse Event
6%
Pulse Rate
6%
Scopus
6%
Positive Syndrome
6%
CNKI Database
6%
Electrical Brain Stimulation
6%
Hospital Setting
5%
